Sofinnova Venture Partners IX L.P. 13D and 13G filings for Galera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-20 6:57 pm Sale | 2023-02-16 | 13D | Galera Therapeutics, Inc. GRTX | Sofinnova Venture Partners IX L.P. | 0 0.000% | -3,083,712 (Position Closed) | Filing |
| 2023-02-03 7:04 pm Sale | 2022-11-09 | 13D | Galera Therapeutics, Inc. GRTX | Sofinnova Venture Partners IX L.P. | 3,083,712 10.800% | -1,098 (-0.04%) | Filing |